We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 9VC market cap is 275.7M. The company's latest EPS is USD -0.2397 and P/E is -7.43.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 20.38M | 233k | 314k |
Operating Income | -17.23M | -104.58M | -135.63M | -141.83M | -125.41M |
Net Income | -14.14M | -169.84M | -167.81M | -152.39M | -40.22M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 62.12M | 111.55M | 414.17M | 305.44M | 293.48M |
Total Liabilities | 2.48M | 16.18M | 28.21M | 39.68M | 49.16M |
Total Equity | 59.64M | 95.37M | 385.96M | 265.77M | 244.32M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -7.85M | -20.77M | -63.25M | -104.47M | -84.12M |
Investing | -9.03M | -28.27M | -81.28M | -86.85M | -53.3M |
Financing | 40.39M | 113.05M | 409.86M | 20.79M | -8.36M |
Market Cap | 275.7M |
Price to Earnings Ratio | -7.43 |
Price to Sales Ratio | 936.84 |
Price to Cash Ratio | 6.63 |
Price to Book Ratio | 1.22 |
Dividend Yield | - |
Shares Outstanding | 167.8M |
Average Volume (1 week) | 10.81k |
Average Volume (1 Month) | 24.82k |
52 Week Change | 57.22% |
52 Week High | 2.529 |
52 Week Low | 0.93 |
Spread (Intraday) | 0.01 (0.55%) |
Company Name | ATAI Life Sciences NV |
Address |
wallstrabe 16 berlin 10179 |
Website | https://www.atai.life |
Industry | intermediate care facilities (8052) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions